Comparison of Lys(B28),Pro(B29)-human insulin analog and regular human insulin in the correction of incidental hyperglycemia

Diabetes Care

Volumn 19, Issue 12, 1996, Pages 1426-1429

  Holleman, Frits ^a   Van Den Brand, Joop J G ^a   Hoven, Roland A R A ^a   Van Der Linden, Jos M ^b   Van Der Tweel, Ingeborg ^c   Hoekstra, Joost B L ^a   Erkelens, D Willem ^d  

^a DEPARTMENT OF SURGERY   (Netherlands)

^b ELI LILLY AND COMPANY   (United States)

^c UTRECHT UNIVERSITY   (Netherlands)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN DERIVATIVE; INSULIN LISPRO; ISOPHANE INSULIN; ANTIDIABETIC AGENT; DRUG DERIVATIVE; INSULIN; RECOMBINANT PROTEIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HUMAN; HYPERGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MALE; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION; AGED; BLOOD; COMPARATIVE STUDY; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS;

ADULT; AGED; BLOOD GLUCOSE; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 1; HUMANS; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RECOMBINANT PROTEINS;

EID: 0029658536     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.19.12.1426     Document Type: Article

References (14)

1. Binder C, Lauritzen T, Faber O, Pramming S: Insulin pharmacokinetics. Diabetes Care 7:188-199, 1984
2. Lauritzen T: Pharmacokinetic and clinical aspects of intensified subcutaneous insulin therapy. PhD thesis. Copenhagen, Denmark, University of Copenhagen, 1985
3. Skyler JS: Insulin pharmacology. Med Clin North Am 72:1337-1354, 1988
4. De Meijer PHEM, Lutterman JA, van't Laar A: The absorption of subcutaneously injected insulin. Neth J Med 34:210-227, 1989
5. Furier SM, Kraegen EW: Quantitative aspects of subcutaneous insulin absorption. Diabetic Med 6:657-665, 1989
6. Woodworth J, Howey D, Lutz S, Santa P, Brady P, Bowsher R: [LYS(B28), PRO(B29)] human insulin: dose ranging versus Humulin R. Diabetologia 36 (Suppl. 1):A155, 1993
7. Antsiferov M, Woodworth JR, Mayorov A, Ristic S, Dedov I: Lower within patient variability in post-prandial glucose-excursion with lispro insulin analog compared with regular insulin. Diabetes 44 (Suppl. 1):214A, 1995
8. Boyle PJ: Glucose clamp investigations: the ups and downs. Diabetes Care 17:239-241, 1994
9. DeFronzo RA, Tobin JD, Andres R: Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237(3):E214-E223, 1979
10. Heinemann L, Richter B: Clinical pharmacology of human insulin. Diabetes Care 16 (Suppl. 3):90-100, 1993
11. Ter Braak EWMT, Bianchi R, Erkelens DW: More suitable action profile for premeal treatment of Lys(B28)Pro(B29) insulin analogue than regular insulin. Diabetologia 36 (Suppl. 1):A30, 1993
12. Radziuk J, Davies J, Pye S, DiMarchi R, Shields J, Chance R: Subcutaneous absorption of fast-acting insulin analogs: kinetics and bio-effectiveness. Diobetologia 35 (Suppl. 1):A3, 1992
13. Howey DC, Bowsher RR, Brunelle RL, Woodworth JR: [Lys(B28), Pro(B29)]-human insulin: a rapidly absorbed analogue of human insulin. Diabetes 43:396-402, 1994
14. Torlone E, Fanelli C, Rambotti AM, Kassi G, Modarelli F, Di Vincenzo A, Epifano L, Ciofetta M, Pampanelli S, Brunetti R Bolli GB: Pharmacokinetics, pharmacodynamics and glucose-counterregulation following subcutaneous injection of the monomeric insulin analogue [Lys(B28), Pro(B29)] in IDDM. Diabetologia 37:713-720, 1994